Analyst consensus rating
Azora Therapeutics Analyst Rating: none
Direct answer
Azora Therapeutics's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $14.00.
Forecast evidence checked November 3, 2026.
Get free Azora Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.89
- Average price target
- $14.00
- High price target
- $14.00
- Low price target
- $14.00
- Low target gap
- +259.9%
- Target upside
- +259.9%
- High target gap
- +259.9%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Azora Therapeutics?
Azora Therapeutics has a verified none consensus. The same dataset has an average price target of $14.00.
How far are Azora Therapeutics's low and high targets from the recorded price?
The low target implies +259.9%, while the high target implies +259.9%.
How many analysts are included in Azora Therapeutics's consensus?
The verified consensus includes 1 analysts.
How is Azora Therapeutics's target upside or downside calculated?
The average target of $14.00 is divided by the recorded price of $3.89, then one is subtracted to produce +259.9%. This does not guarantee a future return.
When was Azora Therapeutics's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.